secwatch.observer — SEC 8-K summary
======================================

Issuer:     Syndax Pharmaceuticals Inc (SNDX)
CIK:        0001395937
Form:       8-K
Filed at:   2022-12-14T23:59:59+00:00
Accession:  0000950170-22-026546
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Syndax closes $172.5M public offering; shares outstanding ~68.1M
----------------------------------------------------------------

- Gross proceeds of $172.5M from 7,840,909 shares at $22.00 per share.
- Underwriters exercised full overallotment for 1,022,727 additional shares.
- Goldman Sachs, J.P. Morgan and Cowen acted as joint book-running managers.
- Shares outstanding after offering stand at 68,100,918 as of December 14, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1395937/000095017022026546/0000950170-22-026546-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1395937/000095017022026546/sndx-20221214.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-026546

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer